Ming‐Cheng Lee
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Immune Response and Inflammation
- Immune cells in cancer
Papers in
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
- Ubiquitin and proteasome pathways 3
- Co-authors
- Shu‐Chen Wei (4 shared papers)Po‐Nien Tsao (3 shared papers)Miao‐Tzu Huang (2 shared papers)Fu‐Ming Tsai (10 shared papers)Mao‐Liang Chen (10 shared papers)Hung‐Chieh Chou (1 shared paper)Yin‐Kai Chen (3 shared papers)Chien‐Yi Chen (1 shared paper)
- Journals
- BioMed Research International (3 papers)Journal of Leukocyte Biology (2 papers)Molecules and Cells (1 paper)BMB Reports (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Ming‐Cheng Lee
34 papers receiving 506 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 98
- Immunology 118
- Molecular Biology 223
- Pulmonary and Respiratory Medicine 104
- Biological Psychiatry 7
Countries citing papers authored by Ming‐Cheng Lee
This map shows the geographic impact of Ming‐Cheng Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Cheng Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Cheng Lee more than expected).
Fields of papers citing papers by Ming‐Cheng Lee
This network shows the impact of papers produced by Ming‐Cheng Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Cheng Lee. The network helps show where Ming‐Cheng Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Cheng Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 87 | |
| 2 | 2011 | 69 | |
| 3 | 2019 | 31 | |
| 4 | 2008 | 28 | |
| 5 | 2021 | 19 | |
| 6 | 2013 | 19 | |
| 7 | 2019 | 18 | |
| 8 | 2019 | 17 | |
| 9 | 2022 | 17 | |
| 10 | 2016 | 16 | |
| 11 | Haptoglobin is a serological biomarker for adenocarcinoma lung cancer by using the ProteomeLab PF2D combined with mass spectrometry. | 2016 | 16 |
| 12 | 2019 | 15 | |
| 13 | 2016 | 15 | |
| 14 | 2018 | 15 | |
| 15 | 2017 | 14 | |
| 16 | 2008 | 13 | |
| 17 | 2023 | 12 | |
| 18 | 2016 | 11 | |
| 19 | 2021 | 11 | |
| 20 | 2019 | 10 |
About Ming‐Cheng Lee
Ming‐Cheng Lee is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Cell Biology, having authored 34 papers that have together received 510 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Ubiquitin and proteasome pathways (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Physiological and biochemical adaptations (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (98 citations), Immunology (118 citations), Molecular Biology (223 citations), Pulmonary and Respiratory Medicine (104 citations) and Biological Psychiatry (7 citations). Ming‐Cheng Lee has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Shu‐Chen Wei, Po‐Nien Tsao, Miao‐Tzu Huang, Fu‐Ming Tsai, Mao‐Liang Chen, Hung‐Chieh Chou, Yin‐Kai Chen, Chien‐Yi Chen, Wu‐Shiun Hsieh and Bor‐Ru Lin. Their work appears in journals such as BioMed Research International, Journal of Leukocyte Biology, Molecules and Cells, BMB Reports and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.